Tachyarrhythmia |
Key ICD Trials
Recent large prospective, randomized clinical trials (MADIT, AVID, CIDS, CASH, MUSTT, and MADIT II) confirmed the efficacy of the ICD as first-line therapy for patients with ventricular tachyarrhythmias and for high-risk, post-MI patients.
Secondary Prevention Trials
ICD VS. Anitiarrythmic Drug Treatment for VF or Sustained VT
Secondary Prevention TrialsAdditional Information
|
©Medtronic, Inc. 2008 • Contact Medtronic • Privacy Statement • Terms of Use • Site Map